Clinical trial
Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney Disease
NCT00456859 · Institute for Health Outcomes and Process Evaluation Reseach, Other · Completed
Key facts
| NCT number | NCT00456859 |
|---|---|
| Title | Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney Disease |
| Official title | Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney Disease (CAP-KD) |
| Acronym | CAP-KD |
| Lead sponsor | Institute for Health Outcomes and Process Evaluation Reseach, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic |
| Intervention type | Drug |
| Interventions | Kremezin |
| Enrollment | 450 |
| Start date | Apr 1, 2004 |
| Completion | Sep 1, 2007 |
| First posted | Apr 5, 2007 |
| Last update posted | Oct 18, 2007 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: